Find

  • All tenders
Tender search/Public Health Institution Clinic for children diseases/Dornase alfa medicine

Dornase alfa medicine

Expired

The competition has expired without a winner being announced.

Deadline
Sep 11,Expired
Procedure
OpenSingle stage
Agreement
Buying goodsover 1 year

Brief

Јавната здравствена установа Клиника за детски болести има потреба од набавка на лекот Дорназа алфа за период од 1 година. Потребно е доставувачот да поседува одлука за трговија на големо со лекови согласно Законот за лекови и медицински средства, како доказ дека се исполнети посебните услови за вршење на дејноста пропишани со закон.

Farmasøytisk engroshandel

Register interest

Previous winners

  • Who are you up against?

    The suppliers who have won similar contracts at Public Health Institution Clinic for children diseases

Will you bid?

The agent sets up the bid and writes the first draft. Free for 14 days.

Qualification requirements

  • Description

    Beslutning om engroshandel med legemidler i henhold til lov om legemidler og legemidler betyr som bevis på at de spesielle vilkårene for utførelse av aktiviteten foreskrevet i loven er oppfylt.

    Documentation Requirement

    Ikke spesifisert.

    Source

    No source found in the documents. Check the requirement against the tender documents.

From the notice

  • Dornase alfa medicine

  • Contact

    javninabavki@ukdetskibolesti.mk
  • Type
    Competition
  • Main code
    Pharmaceutical products
    33600000

Similar active competitions

  • Public Health Institution Clinic for children diseases

    Farmasøytisk engroshandel

    Growth Hormone and Inhalation Therapy

    The Public Health Institution Clinic for Children’s Diseases in North Macedonia requires supplies of growth hormone and inhalation therapy products for a 1-year contract. Suppliers must hold a decision authorising wholesale trade in medicines under the Law on Medicines and Medicine Funds.

    Competition
    Dec 9, 2026(16 days)
  • DAK-Gesundheit

    Farmasøytisk engroshandel

    Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dornase alfa, ATC R05CB13 für die Zeit 01.07.2026 - 30.06.2028

    Die DAK-Gesundheit benötigt pharmazeutische Produkte (Wirkstoff Dornase alfa, ATC R05CB13) für eine nicht-exklusive Rabattvereinbarung nach § 130a Abs. 8 SGB V über 2 Jahre, mit einem maximalen Gesamtwert von 1 EUR. Die Vereinbarung tritt am 01.07.2026 in Kraft und endet am 30.06.2028. Es handelt sich um ein Open-House-Verfahren für ein Original.

    Competition
    May 5, 2028(100+ days)
    €1
  • PHI University Clinic for Surgical Diseases St. Naum Ohridski-Skopje

    Engroshandel med medisinske og husholdningsvarer

    Medical consumables

    PHI University Clinic for Surgical Diseases St. Naum Ohridski–Skopje needs medical consumables supplied under a 1-year contract in North Macedonia. Suppliers must document authorization to conduct wholesale trade in medical devices in accordance with the Law on Medicines and Medical Devices.

    Competition
    Nov 30, 2026(7 days)